Annals of Pharmacotherapy · 2011 · 27 citations · 19 references
The majority of patients receiving warfarin on presentation to the ED had INRs outside the desired therapeutic range. By establishing the impact of warfarin-related adverse events in this population, focused interventions can be established in this setting to address factors that can be targeted to reduce these events.
19
Pharmacology and Management of the Vitamin K Antagonists
Jack Ansell, Jack Hirsh, Elaine M. Hylek et al. · CHEST Journal · 2008 · 2.1K citations
Vitamin K Antagonists, Pharmacological Study, Pharmacology +5
Antithrombotic Therapy for Venous Thromboembolic Disease
Clive Kearon, Susan R. Kahn, Giancarlo Agnelli et al. · CHEST Journal · 2008 · 2K citations
The Pharmacology and Management of the Vitamin K Antagonists
Jack Ansell, Jack Hirsh, L. Poller et al. · CHEST Journal · 2004 · 1.5K citations
Antithrombotic Therapy in Atrial Fibrillation
Daniel E. Singer, Gregory W. Albers, James E. Dalen et al. · CHEST Journal · 2008 · 753 citations